Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.
Fukushi K, Imaoka H, Ikeda M, Mizusawa J, Morizane C, Okusaka T, Kobayashi S, Sasahira N, Shimizu S, Yamazaki K, Okano N, Miwa H, Hara K, Satoi S, Sano K, Sakai K, Sugimoto R, Nakamura K, Terashima T, Ozaka M, Ueno M; JCOG Hepatobiliary and Pancreatic Oncology Group.
Fukushi K, et al. Among authors: shimizu s.
Jpn J Clin Oncol. 2025 Jan 8:hyae188. doi: 10.1093/jjco/hyae188. Online ahead of print.
Jpn J Clin Oncol. 2025.
PMID: 39775866